Cases & Deals

Sunovion establishes global patent portfolio for small molecule drugs for certain CNS disorders and pain

Clients Sunovion Pharmaceuticals Inc.

Jones Day assists Sunovion Pharmaceuticals Inc. in the establishment of a global patent portfolio related to small molecule drugs for the treatment of certain CNS disorders and pain.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.